Position in BIOA
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$3,521,384
New position
Shares Held
201,337
first reported quarter
Ownership
0.453%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Y-Intercept (Hong Kong) Ltd holds $31,681,893 across 15 Drug Manufacturers - Specialty & Generic names. BIOA ranks #4 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
302,995 | $9,126,209 | |
| 2 | VTRS |
Viatris Inc
|
525,863 | $7,104,409 | |
| 3 | PRGO |
PERRIGO Co plc
|
447,451 | $4,805,623 | |
| 4 | BIOA |
BioAge Labs, Inc.
This page
|
201,337 | $3,521,384 | |
| 5 | ZTS |
Zoetis Inc.
|
15,837 | $1,872,091 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
20,236 | $1,045,998 | |
| 7 | HLN |
Haleon plc
|
93,822 | $939,158 | |
| 8 | XERS |
Xeris Biopharma Holdings, Inc.
|
161,793 | $938,399 |
All Filings in BIOA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,521,384 | 201,337 | Shares | Sole | 2026-04-27 | |
| No filing history on record for this holder in this stock. | ||||||